跳至主要内容
临床试验/NCT03962179
NCT03962179Unknown不适用

VAC Stent: A Prospective Feasibility Study for the Treatment of Gastrointestinal Leakage Through a Combination of Covered Nitinol Stent and Negative Pressure Wound Treatment

University Hospital of Cologne2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年9月22日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
2
主要终点
Technique - % of patients with successful implantation of VACStent

研究概览

简要总结

Open, prospective, one-arm feasibility and efficacy study of a European conformity (CE) certified Combination product of two CE certified medical devices in the intended indication.

Evaluation of the suitability of the medical device for sealing leaks in the gastrointestinal tract

详细描述

The investigators analyzed the outcome of using a hybrid medical device (self-expanding metal stents (SEMS) with negative pressure wound therapy) in the treatment of leaks of the upper gastrointestinal tract

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with spontaneous, iatrogenic or postoperative leakage in the esophagus, evidence of leakage through an endoscopic examination
  • Accessibility of the leak with the delivery system of the VAC stent

排除标准

  • Simultaneous participation in other interventional exams
  • Endoscopic inaccessibility of the affected section
  • Full anticoagulation with international normalized ratio (INR) > 1.5 and / or partial thromboplastin time (PTT) > 50 sec, or platelets <20.000 / μl (after therapeutic correction an inclusion is possible)
  • Unstable patients with severe septic disease, who have a clinical history
  • Assessment an immediate operation for safe focus switch-off requires
  • Ileus image with constant vomiting (after nasogastric tube and gastric emptying an inclusion possible)
  • Persons who are in a dependency / employment relationship with the sponsor or examiner stand
  • Accommodation in an institution for judicial or regulatory purposes arrangement

结局指标

主要结局

Technique - % of patients with successful implantation of VACStent

时间窗: From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months

% of patients with successful implantation of VACStent

次要结局

  • Healing of leak - % of patients with successful implantation of VACStent(From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months)
  • Treatment of sepsis(From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months)
  • Migration rate(From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months)
  • Bleeding(From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months)
  • Arrosion of tissue structures(From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months)
  • Sealing of leak - % of patients with successful implantation of VACStent(From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months)

研究者

发起方
University Hospital of Cologne
申办方类型
Other
责任方
Principal Investigator
主要研究者

Seung-Hun Chon

PI

University Hospital of Cologne

研究点 (2)

Loading locations...

相似试验